Literature DB >> 6206721

Frequency of reactivation and variability in expression of X-linked enzyme loci.

T Mohandas, R S Sparkes, D F Bishop, R J Desnick, L J Shapiro.   

Abstract

A mouse-human cell hybrid clone retaining an inactive human X chromosome was treated with 5-azacytidine. Following treatment, expression of the X-linked enzyme markers, hypoxanthine-guanine phosphoribosyltransferase (HPRT), glucose-6-phosphate dehydrogenase (G6PD), phosphoglycerate kinase (PGK), and alpha-galactosidase A (GLA) was examined. Results presented here show that 45 of the 62 clones positive for human HPRT expressed human GLA, while only four of 68 clones negative for human HPRT expressed human GLA. These results strongly suggest that there is coordinate reactivation of GLA and HPRT. Reactivated expression of G6PD was studied in detail. The studies show that 5-azacytidine can induce heritable changes in the inactive human X chromosome resulting in the expression of G6PD activity at a level lower than that from an active human X chromosome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206721      PMCID: PMC1684492     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  31 in total

1.  5-azacytidine-induced re-expression of alleles on the inactive X chromosome in a hybrid mouse cell line.

Authors:  J A Graves
Journal:  Exp Cell Res       Date:  1982-09       Impact factor: 3.905

2.  Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine.

Authors:  F Creusot; G Acs; J K Christman
Journal:  J Biol Chem       Date:  1982-02-25       Impact factor: 5.157

3.  Genetic evidence for the inactivation of a human autosomal locus attached to an inactive X chromosome.

Authors:  T Mohandas; R S Sparkes; L J Shapiro
Journal:  Am J Hum Genet       Date:  1982-09       Impact factor: 11.025

4.  Report of the committee on the genetic constitution of the x and y chromosomes. Oslo Conference (1981): Sixth International Workshop on Human Gene Mapping.

Authors:  O J Miller; M Siniscalco
Journal:  Cytogenet Cell Genet       Date:  1982

5.  Differential expression of steroid sulphatase locus on active and inactive human X chromosome.

Authors:  B R Migeon; L J Shapiro; R A Norum; T Mohandas; J Axelman; R L Dabora
Journal:  Nature       Date:  1982-10-28       Impact factor: 49.962

6.  Evidence for DNA modification in the maintenance of X-chromosome inactivation of adult mouse tissues.

Authors:  V M Chapman; P G Kratzer; L D Siracusa; B A Quarantillo; R Evans; R M Liskay
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Derepression with decreased expression of the G6PD locus on the inactive X chromosome in normal human cells.

Authors:  B R Migeon; S F Wolf; C Mareni; J Axelman
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

8.  Comparison of transformation efficiency of human active and inactive X-chromosomal DNA.

Authors:  L Venolia; S M Gartler
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

9.  Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine.

Authors:  P A Jones; S M Taylor; T Mohandas; L J Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

10.  Transformation with DNA from 5-azacytidine-reactivated X chromosomes.

Authors:  L Venolia; S M Gartler; E R Wassman; P Yen; T Mohandas; L J Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

View more
  10 in total

1.  Hyperexpression of HPRT induced by 5-azacytidine in mouse-human hybrid reactivants.

Authors:  B R Migeon; G G Johnson; S F Wolf; J Axelman; M Schmidt
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

2.  Expression of genes from the human active and inactive X chromosomes.

Authors:  C J Brown; L Carrel; H F Willard
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 3.  Dosage compensation in mammals: why does a gene on the inactive X yield less product than one on the active X?

Authors:  O J Miller
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

4.  Binding sites in mammalian genes and viral gene regulatory regions recognized by methylated DNA-binding protein.

Authors:  X Y Zhang; C K Asiedu; P C Supakar; R Khan; K C Ehrlich; M Ehrlich
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

5.  Human alpha-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme.

Authors:  D F Bishop; D H Calhoun; H S Bernstein; P Hantzopoulos; M Quinn; R J Desnick
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Evidence of genetic instability in tumors and normal nearby tissues.

Authors:  Giuseppe Geraci; Ida D'Elia; Rosanna del Gaudio; Rossella Di Giaimo
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

7.  Cytogenetic and molecular studies on a recombinant human X chromosome: implications for the spreading of X chromosome inactivation.

Authors:  T Mohandas; R L Geller; P H Yen; J Rosendorff; R Bernstein; A Yoshida; L J Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  DNase I sensitivity of Microtus agrestis active, inactive and reactivated X chromosomes in mouse-Microtus cell hybrids.

Authors:  B S Kerem; V Kottusch-Geiseler; V Kalscheuer; R Goitein; K Sperling; M Marcus
Journal:  Chromosoma       Date:  1988       Impact factor: 4.316

9.  Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3' untranslated region.

Authors:  D F Bishop; R Kornreich; R J Desnick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Complete reactivation of X chromosomes from human chorionic villi with a switch to early DNA replication.

Authors:  B R Migeon; M Schmidt; J Axelman; C R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.